Navigation Links
Personalized medicine: Innovative online journal leads the way
Date:11/12/2008

The recent surge of DNA sequence information resulting from deciphering the human genetic code has acted as a catalyst for innovative technological developments that have been vital in the identification of genes associated with disease pathologies. This has allowed for the development of novel genetic therapies to treat a wide range of inherited disorders.

The new genomic era heralds earlier diagnoses, greatly improved prevention and treatment of diseases and enhanced avoidance of side effects from drugs.

Now, the latest information and findings that have an impact on the understanding and management of human health and disease will be available online to physicians around the globe with the launch of BioMed Central's premier medical journal Genome Medicine.

Today, Genome Medicine, an online peer-reviewed open access research journal will be launched at a special event at the 58th annual meeting of the American Society of Human Genetics (ASHG), in Philadelphia.

The launch issue is sponsored by Agilent, the electronic and bio-analytical measurement company. In addition to publishing high-quality research, Genome Medicine serves the international research community as a forum for the discussion and critical review of information about all areas of medicine informed by genomic research.

Genome Medicine will focus on the following areas:

  • Significant advances in the understanding of the genetics, genomics, and epigenetics of disease
  • Computational and systems approaches, including proteomics, metabolomics and transcriptomics, to the understanding and management of disease
  • Genomic epidemiology and public health genomics
  • The application of genomic and post-genomic technologies to clinical practice, with special emphasis on diagnostics and therapeutics
  • Personalized medicine
  • Ethical, social and legal issues relating to genomic medicine and personalized medicine

Speaking of his support for the new journal, Charles Auffray of the Functional Genomics and Systems Biology for Health, Centre National de la Recherche Scientifique (CNRS), France and Section Editor said, "High-throughput experimental and computational technologies are revolutionizing our understanding of life by enabling global systems approaches beyond classical analytical molecular and cellular biology. Genome Medicine is a timely initiative to foster this transition from the highly fragmented scientific and medical landscape to the integrative systems biology and medicine which are needed to translate fundamental discoveries into useful healthcare services for the benefit of individual patients worldwide."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-078-252-57423
BioMed Central
Source:Eurekalert

Related biology news :

1. New genetic research into nicotine addiction shows promise for personalized treatment
2. Emory, Ohio State launch partnership in predictive and personalized health care
3. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
4. Researchers at UH explore patient preferences for personalized medicine
5. Telemedicine: Health alert via satellite
6. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
7. Innovative civil engineering application promises cleaner waters
8. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
9. NIST announces 56 new awards for innovative technology research and development
10. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
11. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: